Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Colorcon
Moodys
McKesson
AstraZeneca

Last Updated: October 22, 2019

DrugPatentWatch Database Preview

Pharmaceutical drugs supplied by: Mylan Pharmaceuticals Inc.

See Plans and Pricing

« Back to Dashboard

Mylan Pharmaceuticals Inc.

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Mylan METHOTREXATE SODIUM methotrexate sodium TABLET;ORAL 081235 ANDA Mylan Pharmaceuticals Inc. 0378-0014-01 100 TABLET in 1 BOTTLE, PLASTIC (0378-0014-01)
Mylan METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 076704 ANDA Mylan Pharmaceuticals Inc. 0378-0018-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0018-01)
Mylan METOPROLOL TARTRATE metoprolol tartrate TABLET;ORAL 076704 ANDA Mylan Pharmaceuticals Inc. 0378-0018-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0018-05)
Mylan DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride TABLET;ORAL 072838 ANDA Mylan Pharmaceuticals Inc. 0378-0023-01 100 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0023-01)
Mylan DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride TABLET;ORAL 072838 ANDA Mylan Pharmaceuticals Inc. 0378-0023-05 500 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (0378-0023-05)
Mylan NADOLOL nadolol TABLET;ORAL 074172 ANDA Mylan Pharmaceuticals Inc. 0378-0028-01 100 TABLET in 1 BOTTLE (0378-0028-01)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Subscribe to access the full database, or Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Boehringer Ingelheim
Colorcon
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
Generic Entry Opportunies 2019 - 2020
 NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.

Links

Follow DrugPatentWatch:

DrugPatentWatch reviews